Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies.

about

Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies.

Item

http://www.wikidata.org/entity/Q41608507

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Characterizing gastrointestina ...... ndoscopic ultrasound-biopsies.

@en

type

Item

label

Characterizing gastrointestina ...... ndoscopic ultrasound-biopsies.

@en

prefLabel

Characterizing gastrointestina ...... ndoscopic ultrasound-biopsies.

@en

P1476

Characterizing gastrointestina ...... ndoscopic ultrasound-biopsies.

@en

P2093

Akif Demir

http://www.w3.org/2001/XMLSchema#string

Bengt Nilsson

http://www.w3.org/2001/XMLSchema#string

Carola Andersson

http://www.w3.org/2001/XMLSchema#string

Fredrik Enlund

http://www.w3.org/2001/XMLSchema#string

Ola Nilsson

http://www.w3.org/2001/XMLSchema#string

P2860

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

Prognostic value of Ki67 index in gastrointestinal stromal tumors.

NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

EUS-guided FNA for the diagnosis of GI stromal cell tumors: sensitivity and cytologic yield.

Histopathology of gastrointestinal stromal tumor.

Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies.

Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncol

P304

5925-5935

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V23.I32.5925

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Per Hedenström

Riadh Sadik

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28932084

http://www.w3.org/2001/XMLSchema#string

P932

5583577

http://www.w3.org/2001/XMLSchema#string